AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vildakos M 500mg/50mg Tablet

Prescription Icon
Prescription Required

Marketer

Elkos Healthcare Pvt Ltd

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Vildakos M 500mg/50mg Tablet

Combiflex DM 500mg/50mg tablets effectively manage elevated blood glucose in individuals with type 2 diabetes. This dual-action medication helps mitigate severe diabetic complications like renal impairment and vision loss, potentially lessening the risk of cardiovascular events. Combiflex DM may be administered independently or alongside other antidiabetic agents. Optimal therapeutic outcomes necessitate adherence to a balanced diet and regular physical activity. Dosage is personalized based on your health status, glucose levels, and concurrent medications. Consuming the tablets with food minimizes gastrointestinal discomfort. Consistent daily intake at the same time maximizes efficacy; discontinuation should only occur under medical supervision. This medication actively regulates blood sugar, safeguarding against future complications. Maintaining your prescribed diet and exercise regimen is crucial. Lifestyle choices significantly influence diabetes control. Commonly reported adverse effects include diarrhea, nausea, vomiting, dyspepsia, headache, pharyngitis, asthenia, GERD, diaphoresis, and anorexia. Hypoglycemia is a potential risk, especially when combined with insulin or sulfonylureas; understanding its symptoms and management is essential. This medication is not universally suitable. Prior to use, inform your physician of any history of renal, hepatic, or cardiac disease, pancreatic issues, or significant alcohol consumption. Pregnant or lactating individuals must consult their doctor. Interactions with other medications are possible; disclose all medications to ensure safety. Alcohol should be avoided due to its hypoglycemic effect. Your doctor will monitor your renal function and glucose levels throughout treatment.

Primary Ingredients of Vildakos M 500mg/50mg Tablet

No information provided. Please provide the text you wish me to rephrase.

Uses of Vildakos M 500mg/50mg Tablet

Managing type 2 diabetes

Major Benefits of Vildakos M 500mg/50mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Vildakos M 500mg/50mg Tablets. Ingest the tablets whole; do not crush, chew, or divide them. Administer this medication with a meal.

Common Side effects of Vildakos M 500mg/50mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Vildakos M 500mg/50mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Vildakos M 500mg/50mg Tablet whole; avoid chewing, crushing, or breaking it. Administer this medicine with food.

How Vildakos M 500mg/50mg Tablet works:

Each Vildakos M 500mg/50mg tablet contains a dual-action formulation of two anti-diabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Vildakos M 500mg/50mg Tablet with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Vildakos M 500mg/50mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing this medication. Seek medical advice before using this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Vildakos M 500mg/50mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Vildakos M 500mg/50mg tablets cautiously, potentially requiring a modified dosage. Physician consultation is advised.

LiverLiverUNSAFE

Patients with liver impairment should likely avoid Vildakos M 500mg/50mg tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Vildakos M 500mg/50mg Tablet :

Should you forget to take a Vildakos M 500mg/50mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vildakos M 500mg/50mg Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Vildakos M 500mg/50mg Tablet

Vildakos M 500mg/50mg Tablets rarely cause hypoglycemia by themselves; however, insufficient caloric intake while using this medication may lead to low blood sugar. Symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness may indicate hypoglycemia. These symptoms are more pronounced if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Regular blood sugar monitoring is therefore crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Vildakos M 500mg/50mg Tablets. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not take other medications without your doctor's advice.
Vildakos M 500mg/50mg Tablets are contraindicated in patients with allergies to any ingredient or excipient. This medication is also harmful for those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions provided. Discard any unused medication safely and prevent access by children, pets, and others.
Vildakos M 500mg/50mg tablets combine the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated for individuals under 18.
Vildakos M 500mg/50mg Tablets can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. Seek immediate medical attention and discontinue Vildakos M 500mg/50mg Tablets if you experience these symptoms.
Prolonged use of Vildakos M 500mg/50mg Tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological complications.
Vildakos M 500mg/50mg Tablet is safe when used as directed by your doctor. However, even with proper use, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and low blood sugar (especially if you also take insulin or sulphonylurea) may occur. Report any persistent side effects to your physician.
Vildakos M 500mg/50mg Tab...
140
MRP 162
13% off